How Much Calcium Is in Your Drinking Water? A Survey of Calcium Concentrations in Bottled and Tap Water and Their Significance for Medical Treatment and Drug Administration
暂无分享,去创建一个
Joseph M. Lane | J. Lane | Simon Morr | Esteban Cuartas | Basil Alwattar | Simon Morr | Basil J. Alwattar | Esteban Cuartas
[1] I. Reid,et al. Effect of calcium supplementation on bone loss in postmenopausal women. , 1993, The New England journal of medicine.
[2] K. Resch,et al. Calcium Supplementation with Calcium-Rich Mineral Waters: A Systematic Review and Meta-analysis of its Bioavailability , 2000, Osteoporosis International.
[3] L. Pylkkänen,et al. Timing of food intake has a marked effect on the bioavailability of clodronate. , 2000, Bone.
[4] J. Lin,et al. Bisphosphonates: a review of their pharmacokinetic properties. , 1996, Bone.
[5] R. Recker,et al. Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis , 1996 .
[6] S. Cummings,et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.
[7] H. Fleisch,et al. Sodium EDTA enhances intestinal absorption of two bisphosphonates , 1991, Calcified Tissue International.
[8] R. Heaney,et al. Absorption of Calcium as the Carbonate and Citrate Salts, with Some Observations on Method , 1999, Osteoporosis International.
[9] G. Rennert,et al. Calcium supplementation provides an extended window of opportunity for bone mass accretion after menarche. , 2003, The American journal of clinical nutrition.
[10] K. Goa,et al. Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease. , 2001, Drugs.
[11] G. Rodan,et al. Preclinical pharmacology of alendronate , 2005, Osteoporosis International.
[12] P. Geusens,et al. Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. , 1996, Bone.
[13] G. Guyatt,et al. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. , 2002, Endocrine reviews.
[14] L. Davis. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. , 1998, Journal of nurse-midwifery.
[15] Jacques P. Brown,et al. Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1998 .
[16] D. Burr,et al. Regional patterns of bone loss and altered bone remodeling in response to calcium deprivation in laboratory rabbits , 1990, Calcified Tissue International.
[17] J Dequeker,et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. , 1995, The New England journal of medicine.
[18] M. Espallargues,et al. Identifying Bone-Mass-Related Risk Factors for Fracture to Guide Bone Densitometry Measurements: A Systematic Review of the Literature , 2001, Osteoporosis International.
[19] B. Gertz,et al. Pharmacokinetics of Alendronate , 1999, Clinical pharmacokinetics.
[20] G E Dallal,et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.
[21] B. Dawson-Hughes. Vitamin D and Calcium: Recommended Intake for Bone Health , 1998, Osteoporosis International.
[22] L. Schiller,et al. Gastrointestinal absorption of calcium from milk and calcium salts. , 1987, The New England journal of medicine.
[23] Theodore L. Brown. Chemistry: The Central Science , 1981 .
[24] R. Heaney. Optimal calcium intake. , 1995, JAMA.
[25] Heinz Valtin,et al. “ Drink at least eight glasses of water a day . ” Really ? Is there scientific evidence for “ 8 8 ” ? , 2002 .
[26] Kay Dickersin,et al. Osteoporosis prevention, diagnosis, and therapy. , 2000, NIH consensus statement.
[27] B. Nordin. Calcium requirement is a sliding scale. , 2000, The American journal of clinical nutrition.
[28] E. Orwoll,et al. Alendronate for the treatment of osteoporosis in men. , 2000, The New England journal of medicine.